AI assistant
Marlin Global Limited — Director's Dealing 2017
Sep 13, 2017
66231_rns_2017-09-13_9fe7184c-89c6-40c1-a5c5-2b5b5c7a49a1.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [99 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| ToNZX Limited; and | ||
|---|---|---|
| Name of listedissuer: | MarlinGlobal Limited | |
| Date this disclosuremade: | 13-Sep-17 | |
| Date of last disclosure: | 8-Sep-17 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | Carmel MiringaFisher | |
| Name of listedissuer: | MarlinGlobal Limited | |
| Name of related body corporate (ifapplicable): | n/a | |
| Position heldin listedissuer: | Director | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
| Class ofaffected quotedfinancialproducts: | Ordinary shares | |
| Nature ofthe affectedrelevantinterest(s): | Beneficial interest | |
| For that relevant interest- | ||
| Number heldinclass before acquisitionordisposal: | 550,567ordinary shares | |
| Number heldinclass afteracquisitionordisposal: | 679,388 ordinary shares | |
| Currentregisteredholder(s): | ASB Nominees | |
| Registeredholder(s) once transfers areregistered: | ASB Nominees | |
| Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicable) | ||
| Type ofaffected derivative: | ||
| Class ofunderlyingfinancialproducts: | ||
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial | ||
| products (ifany): | ||
| Astatement as towhetherthe derivativeis cashsettled orphysically settled: | ||
| Maturity date ofthe derivative (ifany): | ||
| Expiry date ofthe derivative(ifany): | ||
| The price specifiedinthe terms ofthe derivative (ifany): | ||
| Any other details needed to understand how the amount of the consideration payable | ||
| under the derivative or the value of the derivative is affected by the value of the | ||
| underlyingfinancialproducts: | ||
| _For that derivative,- _ | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | ||
| interestinthe derivative: | ||
| Details of transactions giving rise to acquisition or disposal | ||
| Total numberoftransactions towhich noticerelates: | Eight | |
| Details of transactions requiring disclosure- | ||
| Date of transaction: | a) 06 September (4 trades)b)12September 2017(4trades) | |
| Nature oftransaction: | Acquisitionon market | |
| Name ofany otherparty orparties to the transaction(if known): | None | |
| a) $15,225.52 (total for 1 trade) | ||
| b) $2,544.61 (total for 1 trade) | ||
| The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into acash value, describe the consideration: | c) $22,303.72 (total for 1 trade)d) $1,583.16 (total for 1 trade)e) $29,500.99 (total for 1 trade)f) $25,431.69 (total for 1 trade) | |
| g) $6,129.18 (total for 1 trade) | ||
| h) $487.13(total for 1 trade) | ||
| a) 19,000 shares | ||
| b) 3,176 shares | ||
| c) 27,824 shares | ||
| Number of financial products to which the transaction related: | d) 2,000 sharese) 36,821 shares | |
| f) 31,742 shares | ||
| g) 7,650 shares | ||
| h) 608 shares |
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any): Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative: Details of derivative,- The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price's specified terms (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative relevant interest,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:
Not during closed period n/a n/a Ordinary shares Non-beneficial interest 1,273,142 ordinary shares ASB Nominees
==> picture [57 x 28] intentionally omitted <==
13-Sep-17